Abstract
There are almost no studies about rare diseases in general practice. This study examined care characteristics of active rare disease patients in the Belgian Network of Sentinel General Practices (SGP) and the importance of rare diseases in general practice by its caseload, general practitioner (GP)–patient encounter frequency and nationwide prevalence. The SGP reported data about: (i) the number of active rare disease patients in 2015; and (ii) characteristics of one to three most recently seen patients. Rare diseases were matched against Orphanet (www.orpha.net). GP encounter frequency and patients’ age were compared to the total general practice population. Details from 121 active patients (median age: 44, interquartile range (IQR) 24–60) showed that for 36.9% the GP had been the first caregiver for the rare disease and for 35.8% the GP established a diagnostic referral. GPs rated their knowledge about their patients’ disease as moderate and used Orphanet for 14.9% of patients. Any active rare disease patients (median: 1, IQR 0–2) were reported by 66 of 111 SGP. Compared to the total general practice population, the mean GP encounter frequency was higher (7.3; 95% confidence intervals (CI) 6.1–8.5 versus 5.4; 95% CI 5.4–5.4). The prevalence of rare diseases in the Belgian general practice population was estimated at 12.0 (95% CI 10.3–13.9) per 10,000. This study acknowledges the important role of GPs in rare disease care. Knowledge and use of Orphanet by GPs could be improved.
Highlights
During the past two decades, rare diseases have become a major public health concern, largely as a result of advocacy by patient organizations, physicians, researchers and policy makers
For determinants of the number of rare disease patients per Sentinel General Practices (SGP), we report incident rate ratios (IRRs) with 95% confidence intervals (CI)
A higher age of the general practitioner (GP) was the only determinant of study response (Odds Ratio (OR) 6.5; 95%
Summary
During the past two decades, rare diseases have become a major public health concern, largely as a result of advocacy by patient organizations, physicians, researchers and policy makers. A symposium on primary care for rare disease patients guided this study [4]. In Europe, rare diseases were defined by the threshold for rarity as “life threatening or chronically debilitating conditions that affect no more than 5 in 10,000 people” [5]. An estimated 6% to 8% of the European population is affected by a rare disease [6]. Little is known about the magnitude of the rare disease patient population and the care they receive in general practice. A PubMed search (January 2017) resulted in six original research articles on rare diseases in the general practice
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Environmental Research and Public Health
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
